Study details
Enrolling now
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Cleerly, Inc.
NCT IDNCT06112418ClinicalTrials.gov data as of Apr 2026
Target enrollment
7,500
Study length
about 5 years
Ages
55+
Locations
123 sites in AZ, CA, CO +29
What this study is about
Researchers are testing whether a Cleerly CAD Staging System-based care strategy reduces cardiovascular events compared with risk factor-based care in people at increased risk for heart disease but without symptoms. The trial will last 1825 days and involve approximately 7500 participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use The Cleerly CAD Staging System
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized (Open Label)
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Endocrinology